118 related articles for article (PubMed ID: 37866762)
1. Patterns of Failure, Low-Volume Relapse, and Subsequent Ablative Management in Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation and Consolidation Immune Checkpoint Inhibitors.
Friedes C; Iocolano M; Lee SH; Li B; Duan L; Levin WP; Cengel KA; Sun LL; Aggarwal C; Marmarelis ME; Doucette A; Cohen RB; Xiao Y; Langer CJ; Bradley J; Feigenberg SJ; Yegya-Raman N
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1435-1444. PubMed ID: 37866762
[TBL] [Abstract][Full Text] [Related]
2. Locoregional tumor failure after definitive radiation for patients with stage III non-small cell lung cancer.
Rajpara RS; Schreibmann E; Fox T; Stapleford LJ; Beitler JJ; Curran WJ; Higgins KA
Radiat Oncol; 2014 Aug; 9():187. PubMed ID: 25154893
[TBL] [Abstract][Full Text] [Related]
3. RTOG 0417: efficacy of bevacizumab in combination with definitive radiation therapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma.
Schefter T; Winter K; Kwon JS; Stuhr K; Balaraj K; Yaremko BP; Small W; Sause W; Gaffney D;
Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):101-5. PubMed ID: 24331655
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Tumor Mutational Burden, Progression-Free Survival, and Local-Regional Control in Patents with Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and Durvalumab.
Lebow ES; Shepherd A; Eichholz JE; Offin M; Gelblum DY; Wu AJ; Simone CB; Schoenfeld AJ; Jones DR; Rimner A; Chaft JE; Riaz N; Gomez DR; Shaverdian N
JAMA Netw Open; 2023 Jan; 6(1):e2249591. PubMed ID: 36602799
[TBL] [Abstract][Full Text] [Related]
5. Concurrent chemoradiation for resected gall bladder cancers and cholangiocarcinomas.
Fareed MM; DeMora L; Esnaola NF; Denlinger CS; Karachristos A; Ross EE; Hoffman J; Meyer JE
J Gastrointest Oncol; 2018 Aug; 9(4):762-768. PubMed ID: 30151273
[TBL] [Abstract][Full Text] [Related]
6. Patterns of locoregional failure in locally advanced non-small cell lung cancer treated with definitive conformal radiotherapy: Results from the Gating 2006 trial.
Jouglar E; Isnardi V; Goulon D; Ségura-Ferlay C; Ayadi M; Dupuy C; Douillard JY; Mahé MA; Claude L
Radiother Oncol; 2018 Feb; 126(2):291-299. PubMed ID: 29203290
[TBL] [Abstract][Full Text] [Related]
7. Definitive Radiation With Nodal Boost for Patients With Locally Advanced Breast Cancer.
Purswani JM; Oh C; Teruel JR; Xiao J; Barbee DL; Maisonet OG; Perez CA; Huppert NE; Gerber NK
Pract Radiat Oncol; 2023; 13(2):e103-e114. PubMed ID: 36435389
[TBL] [Abstract][Full Text] [Related]
8. Platinum-based regimens versus cetuximab in definitive chemoradiation for human papillomavirus-unrelated head and neck cancer.
Beckham TH; Barney C; Healy E; Wolfe AR; Branstetter A; Yaney A; Riaz N; McBride SM; Tsai CJ; Kang J; Yu Y; Chen L; Sherman E; Dunn L; Pfister DG; Tan J; Rupert R; Bonomi M; Zhang Z; Lobaugh SM; Grecula JC; Mitchell DL; Wobb JL; Miller ED; Blakaj DM; Diavolitsis VM; Lee N; Bhatt AD
Int J Cancer; 2020 Jul; 147(1):107-115. PubMed ID: 31609479
[TBL] [Abstract][Full Text] [Related]
9. Assessing failure patterns of radical intent radiation strategies in patients with locally advanced carcinoma of the esophagus.
Mishra S; Ahmad F; Singh S; Singh RK; Das KJM; Kumar S
Cancer Rep (Hoboken); 2021 Jun; 4(3):e1332. PubMed ID: 33369258
[TBL] [Abstract][Full Text] [Related]
10. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
[TBL] [Abstract][Full Text] [Related]
11. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013257. PubMed ID: 33930176
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of factors associated with loco-regional failure and survival in limited disease small cell lung cancer patients treated with chemoradiotherapy.
Winther-Larsen A; Hoffmann L; Moeller DS; Khalil AA; Knap MM
Acta Oncol; 2015; 54(9):1574-81. PubMed ID: 26203924
[TBL] [Abstract][Full Text] [Related]
13. Pneumonitis Rates Before and After Adoption of Immunotherapy Consolidation in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiation.
Yegya-Raman N; Friedes C; Lee SH; Iocolano M; Duan L; Wang X; Li B; Aggarwal C; Cohen RB; Su W; Doucette A; Levin WP; Cengel KA; DiBardino D; Teo BK; O'Reilly SE; Sun L; Bradley JD; Xiao Y; Langer CJ; Feigenberg SJ
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1445-1454. PubMed ID: 37619788
[TBL] [Abstract][Full Text] [Related]
14. Patterns of regional failure in stage III non-small cell lung cancer treated with neoadjuvant chemoradiation therapy and resection.
Garg S; Gielda BT; Turian JV; Liptay M; Warren WH; Bonomi P; Sher DJ
Pract Radiat Oncol; 2013; 3(4):287-93. PubMed ID: 24674400
[TBL] [Abstract][Full Text] [Related]
15. Association of Body Mass Index With Outcomes Among Patients With Head and Neck Cancer Treated With Chemoradiotherapy.
Ma SJ; Khan M; Chatterjee U; Santhosh S; Hashmi M; Gill J; Yu B; Iovoli A; Farrugia M; Wooten K; Gupta V; McSpadden R; Yu H; Kuriakose MA; Markiewicz MR; Al-Afif A; Hicks WL; Seshadri M; Ray AD; Repasky E; Singh AK
JAMA Netw Open; 2023 Jun; 6(6):e2320513. PubMed ID: 37368400
[TBL] [Abstract][Full Text] [Related]
16. Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques.
Leeman JE; Li JG; Pei X; Venigalla P; Zumsteg ZS; Katsoulakis E; Lupovitch E; McBride SM; Tsai CJ; Boyle JO; Roman BR; Morris LGT; Dunn LA; Sherman EJ; Lee NY; Riaz N
JAMA Oncol; 2017 Nov; 3(11):1487-1494. PubMed ID: 28542679
[TBL] [Abstract][Full Text] [Related]
17. Patterns of locoregional failure in stage III non-small cell lung cancer treated with definitive chemoradiation therapy.
Garg S; Gielda BT; Kiel K; Turian JV; Fidler MJ; Batus M; Bonomi P; Sher DJ
Pract Radiat Oncol; 2014; 4(5):342-348. PubMed ID: 25194104
[TBL] [Abstract][Full Text] [Related]
18. Treatment-related pulmonary adverse events induced by chemoradiation and Durvalumab affect survival in locally advanced non-small cell lung cancer.
Xu T; Wu L; Gandhi S; Jing W; Nguyen QN; Chen A; Chang JY; Nurieva R; Sheshadri A; Altan M; Lee PP; Lin SH; Liao Z
Radiother Oncol; 2022 Nov; 176():149-156. PubMed ID: 36209942
[TBL] [Abstract][Full Text] [Related]
19. Could excision repair cross-complementing group-1 mRNA expression from peripheral blood lymphocytes predict locoregional failure with cisplatin chemoradiation for locally advanced laryngeal cancer?
Raturi VP; Wu CT; Mohammad S; Hojo H; Bei Y; Nakamura M; Okumura M; Rachi T; Singh R; Gupta R; Parmar D; Hasan F; Gaur J; Kishan D; Kumar S; Badajena A; Katepogu P; Shigematsu N
Asia Pac J Clin Oncol; 2020 Apr; 16(2):e19-e26. PubMed ID: 31612639
[TBL] [Abstract][Full Text] [Related]
20. Predictors of Locoregional Failure and Impact on Overall Survival in Patients With Resected Exocrine Pancreatic Cancer.
Merrell KW; Haddock MG; Quevedo JF; Harmsen WS; Kendrick ML; Miller RC; Hallemeier CL
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):561-70. PubMed ID: 26867884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]